Governments’ favorable policies regarding eradication of polio is the factor responsible for the polio vaccines market growth. The polio eradication programs are being conducted at a larger scale worldwide. Though Pakistan and Afghanistan are still struggling with polio, the UNICEF’s guidelines regarding polio vaccination are being adhered to in the rest of the parts of the world.
Companies operating in the polio vaccines market are upscaling the production of polio vaccines in order to cater to the governments’ vision of eradicating polio worldwide. They are collaborating with the local players to meet the increasing demand for polio vaccines, especially in the developing and densely populated countries like India.
Polio vaccines are categorized into a weakened poliovirus administered orally (called oral polio vaccine (OPV)) and an inactivated poliovirus (IPV) that can be injected into the body. The CDC recommends that every child be protected against polio/poliomyelitis as a part of series of the routine childhood vaccines.
IPV is the only vaccine given all over the U.S. since the year 2000. The oral polio vaccine is used in the other countries.
Four doses of polio vaccine are recommended, with one dose at 2 months, 4 months, 6-18 months, and 4-6 years of age respectively.
Massive vaccination programmes are conducted at regular intervals worldwide, which have reduced the occurrence of polio in Pakistan and Afghanistan, but not yet eradicated.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The year 1980 witnessed more than 50,000 cases of polio reported. However, by the year 2021, the number had come down to 649.
The governments across the globe are making efforts on continuous basis to eradicate polio. The pulse polio immunization programmes are being launched, which are helping in drastically reducing the number of polio patients.
As per the WHO, out of the three strains of wild poliovirus (type 1, type 2, and type 3), the wild poliovirus type 2 was wiped off in 1999 and wild poliovirus type 3 in 2020. It further states that as of the year 2022, endemic wild poliovirus type 1 stays in two countries, viz Pakistan and Afghanistan.
Relentless efforts put in by the governments to do away with polio are thus contributing toward polio vaccines market demand.
As a part of Global Polio Eradication Initiative, the emphasis is on local and national campaigns in the countries at the highest risk of polio with children being provided with multiple doses of oral polio vaccine (OPV).
The major strategies being tabled for eradicating polio are conduction of national immunization days (NIDs) in the polio endemic countries, attainment of higher routine coverage with atleast three doses of OPV, establishment of a sensitive system of acute flaccid paralysis (AFB) surveillance for tracking wild poliovirus circulation, and conduction of ‘mopping-up immunization’ on polio being reduced to focal transmission.
The UNICEF also ascertains that more than 400 million children get vaccinated against polio every year.
Continual efforts taken to eradicate polio are thus boosting the polio vaccines market revenue.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest polio vaccines market analysis, North America dominated the poliovirus immunization landscape in 2023 and the dominance is expected to continue during the forecast period.
This is attributed to the U.S. and Canada being extra cautious regarding the preventive measures to be taken against poliomyelitis. The vaccination drives are being prioritized in these countries with 100% support by the governments.
Asia Pacific also holds a noticeable polio vaccines market share. This is ascribed to Pakistan and Afghanistan accounting for majority of cases of polio worldwide. On the other hand, various nations of Asia Pacific have put various policies into practice.
For instance, the Government of India has begun with several programmes for boosting immunization rates and raise the access quotient regarding polio vaccines.
The polio vaccines market manufacturers are engaging in new product launches to establish a stronger foothold in the poliomyelitis vaccine landscape. For instance, in September 2020, Sanofi Pasteur India announced that it had launched Tetraxim (DTaP-IPV), a booster vaccine recommended for the preschoolers and providing protection against tetanus, pertussis, diphtheria, and polio.
Sanofi S.A., GSK plc, Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL), Serum Institute of India, Panacea Biotec, Beijing Tiantan Biological Products Corp, Bio-Med Healthcare Products Pvt. Ltd. Halffkine Bio-Pharmaceuticals, Sinovac Biotech Ltd., and Pfizer Inc. are some of the key players covered in the polio vaccines market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 794.1 Mn |
| Market Forecast (Value) in 2034 | US$ 1.4 Bn |
| Growth Rate (CAGR) | 5.0% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 794.1 Mn in 2023
It is projected to grow at a CAGR of 5.0% from 2024 to 2034
Conducive government policies and increase in the number of polio eradication activities
Hospitals & clinics held the largest share in 2023.
North America was the dominant region in 2023
Sanofi S.A., GSK plc, Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL), Serum Institute of India, Panacea Biotec, Beijing Tiantan Biological Products Corp, Bio-Med Healthcare Products Pvt. Ltd. Halffkine Bio-Pharmaceuticals, Sinovac Biotech Ltd., and Pfizer Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Polio Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Polio Vaccines Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Polio Vaccines Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. Inactivated Polio Vaccine (IPV)
6.3.2. Oral Polio Vaccine (OPV)
6.4. Market Attractiveness Analysis, by Type
7. Global Polio Vaccines Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Public
7.3.2. Private
7.4. Market Attractiveness Analysis, by Application
8. Global Polio Vaccines Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Public Services
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Polio Vaccines Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Polio Vaccines Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
10.3.1. Inactivated Polio Vaccine (IPV)
10.3.2. Oral Polio Vaccine (OPV)
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Public
10.4.2. Private
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Public Services
10.5.3. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Polio Vaccines Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
11.3.1. Inactivated Polio Vaccine (IPV)
11.3.2. Oral Polio Vaccine (OPV)
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Public
11.4.2. Private
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Public Services
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Polio Vaccines Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
12.3.1. Inactivated Polio Vaccine (IPV)
12.3.2. Oral Polio Vaccine (OPV)
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Public
12.4.2. Private
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Public Services
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Polio Vaccines Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
13.3.1. Inactivated Polio Vaccine (IPV)
13.3.2. Oral Polio Vaccine (OPV)
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Public
13.4.2. Private
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Public Services
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Polio Vaccines Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
14.3.1. Inactivated Polio Vaccine (IPV)
14.3.2. Oral Polio Vaccine (OPV)
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Public
14.4.2. Private
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Public Services
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Sanofi S.A.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. GSK plc
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL)
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Serum Institute of India
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Panacea Biotec
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Beijing Tiantan Biological Products Corp
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Bio-Med Healthcare Products Pvt. Ltd.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Halffkine Bio-Pharmaceuticals
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Sinovac Biotech Ltd.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Pfizer Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 02: Global Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Polio Vaccines Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Polio Vaccines Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 07: North America Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Polio Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 11: Europe Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Polio Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 15: Asia Pacific Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Polio Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 19: Latin America Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Polio Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Polio Vaccines Market Size (US$ Mn) Forecast, by Type, 2020-2034
Table 23: Middle East & Africa Polio Vaccines Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa Polio Vaccines Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Polio Vaccines Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Polio Vaccines Market Revenue (US$ Mn), by Type, 2023
Figure 03: Global Polio Vaccines Market Value Share, by Type, 2023
Figure 04: Global Polio Vaccines Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global Polio Vaccines Market Value Share, by Application, 2023
Figure 06: Global Polio Vaccines Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Polio Vaccines Market Value Share, by End-user, 2023
Figure 08: Global Polio Vaccines Market Value Share, by Region, 2023
Figure 09: Global Polio Vaccines Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 11: Global Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: Global Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Polio Vaccines Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Polio Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Polio Vaccines Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Polio Vaccines Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 22: North America Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Polio Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Polio Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Polio Vaccines Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 31: Europe Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Polio Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Polio Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Polio Vaccines Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 40: Asia Pacific Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Polio Vaccines Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Polio Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Polio Vaccines Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 49: Latin America Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Polio Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Polio Vaccines Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Polio Vaccines Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Polio Vaccines Market Value Share Analysis, by Type, 2023 and 2034
Figure 58: Middle East & Africa Polio Vaccines Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa Polio Vaccines Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Polio Vaccines Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Polio Vaccines Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa Polio Vaccines Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Polio Vaccines Market
